The Prescription Drug Pricing Moment: Using Public Health Analysis to Clarify the Fair Competition Debate on Prescription Drug Pricing and Consumer Welfare

Journal of Law, Medicine and Ethics 45 (s1):45-49 (2017)
  Copy   BIBTEX

Abstract

Fair competition law and public health law talk past each other when discussing pharmaceutical pricing and distribution. The former cannot agree on the relevant definition of consumer welfare. The latter does not fully comprehend the highly complex but inherently collective nature of pharmaceutical drug acquisition in the United States. This essay proposes to inject public health discourse into this debate to enrich it, focus it, and render it more accessible to those who must live by its outcome.

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,219

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Demand for a Medicare Prescription Drug Benefit: Exploring Consumer Preferences under a Managed Competition Framework.Richard R. Cline & David A. Mott - 2003 - Inquiry: The Journal of Health Care Organization, Provision, and Financing 40 (2):169-183.
Effect of prescription drug coverage on the elderly's use of prescription drugs.Nasreen Khan & Robert Kaestner - 2009 - Inquiry: The Journal of Health Care Organization, Provision, and Financing 46 (1):33-45.
Just a Spoonful of Sugar: Drug Safety for Pediatric Populations.Barbara A. Noah - 2009 - Journal of Law, Medicine and Ethics 37 (2):280-291.

Analytics

Added to PP
2017-07-21

Downloads
17 (#819,600)

6 months
2 (#1,157,335)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references